Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1186/s13075-017-1339-4

http://scihub22266oqcxt.onion/10.1186/s13075-017-1339-4
suck pdf from google scholar
C5461689!5461689 !28587670
unlimited free pdf from europmc28587670
    free
PDF from PMC    free
html from PMC    free

Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=28587670 &cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215

suck abstract from ncbi

pmid28587670
      Arthritis+Res+Ther 2017 ; 19 (1 ): 125
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • High mobility group box-1 contributes to anti-myeloperoxidase antibody-induced glomerular endothelial cell injury through a moesin-dependent route #MMPMID28587670
  • Deng H ; Wang C ; Chang DY ; Hu N ; Chen M ; Zhao MH
  • Arthritis Res Ther 2017[Jun]; 19 (1 ): 125 PMID28587670 show ga
  • BACKGROUND: Our previous study found that circulating and urinary levels of high mobility group box-1 (HMGB1) were closely associated with disease activity in patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). Moreover, HMGB1 participates in ANCA-induced neutrophil activation. Cross-reactivity between moesin and anti-myeloperoxidase (MPO) antibody has been reported in both human and mouse. The current study investigated whether HMGB1 participated in MPO-ANCA-induced glomerular endothelial cell (GEnC) injury, which is one of the most important aspects in the pathogenesis of AAV. METHODS: The effects of HMGB1 on expression of moesin on GEnCs and anti-MPO antibody binding to GEnCs were measured. MPO expression on GEnCs was explored. The effects of HMGB1 in MPO-ANCA induced GEnC injury were measured, during which the role of moesin was explored. Antagonists for various relevant receptors were employed. RESULTS: Sera from AAV patients at the active stage could mediate GEnC injury, while this effect could be attenuated by preblocking HMGB1. HMGB1 could increase the expression of moesin on GEnCs and the binding of anti-MPO antibody to moesin. The colocalization of moesin expression and anti-MPO antibody binding can be detected. Little, if any, MPO was expressed in GEnCs. HMGB1 increased GEnC activation and injury in the presence of patient-derived MPO-ANCA-positive IgGs through moesin. The effects of HMGB1 on expression of moesin on GEnCs, anti-MPO antibody binding to GEnCs, GEnC activation and injury were mainly toll like receptor 4 (TLR4) dependent. CONCLUSIONS: HMGB1 can increase the expression of moesin but not MPO on GEnCs, and can further participate in MPO-ANCA-induced GEnC activation and injury by cross-reactivity between moesin and anti-MPO antibody.
  • |Adult [MESH]
  • |Aged [MESH]
  • |Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/blood/*immunology/metabolism [MESH]
  • |Autoantibodies/*immunology/metabolism [MESH]
  • |Cell Survival/drug effects/immunology [MESH]
  • |Cells, Cultured [MESH]
  • |Endothelial Cells/drug effects/*immunology/metabolism [MESH]
  • |Female [MESH]
  • |HMGB1 Protein/*immunology/metabolism/pharmacology [MESH]
  • |Humans [MESH]
  • |Immunoglobulin G/immunology/metabolism/pharmacology [MESH]
  • |Kidney Glomerulus/immunology/metabolism/pathology [MESH]
  • |Male [MESH]
  • |Microfilament Proteins/*immunology/metabolism [MESH]
  • |Middle Aged [MESH]
  • |Peroxidase/*immunology [MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box